106 related articles for article (PubMed ID: 4882472)
1. A clinical study of fluorouracil.
Nadler SH; Moore GE
Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
[No Abstract] [Full Text] [Related]
2. Combination chemotherapy in gastrointestinal cancer.
Reitemeier RJ; Moertel CG; Hahn RG
Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
[No Abstract] [Full Text] [Related]
3. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
Hill GJ; Grage TB; Wilson W; Ansfield FJ
J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
[No Abstract] [Full Text] [Related]
4. [Preliminary results of clinical trial of the antineoplastic antibiotic bruneomycin].
Garim AM; Lorie IuI; Reĭzinger MA; Shkarenkov VA; Durnov LA
Antibiotiki; 1967 Jul; 12(7):609-19. PubMed ID: 4299328
[No Abstract] [Full Text] [Related]
5. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
6. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
7. Oral administration of fluorouracil. A preliminary trial.
Nadler SH
Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
[No Abstract] [Full Text] [Related]
8. Experience with ftorafur treatment in breast cancer.
Karev NI; Blokhina NG; Vozny EK; Pershin MP
Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
[No Abstract] [Full Text] [Related]
9. [Toxicities associated with chemotherapy in colorectal cancer].
Ura T; Shirao K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():374-8. PubMed ID: 14574916
[No Abstract] [Full Text] [Related]
10. [A clinical study of N-nitrosomethylurea].
Vermel' EM; Korman NP; Milonov BV; Evseenko LS; Orlova RS
Vopr Onkol; 1970 May; 16(5):31-7. PubMed ID: 4915916
[No Abstract] [Full Text] [Related]
11. Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.
Innocenti F; Ratain MJ
Clin Cancer Res; 2002 May; 8(5):1314; author reply 1315-6. PubMed ID: 12006555
[No Abstract] [Full Text] [Related]
12. Corticosteroids and fluorouracil toxicity.
Horton J; Olson KB; Hosley HF
Arch Intern Med; 1966 Jun; 117(6):775-7. PubMed ID: 5327216
[No Abstract] [Full Text] [Related]
13. Toxicity studies of fluorouracil used with adrenalectomy in breast cancer.
Piro AJ; Wilson RE; Hall TC; Aliapoulios MA; Nevinny HB; Moore FD
Arch Surg; 1972 Jul; 105(1):95-9. PubMed ID: 5031606
[No Abstract] [Full Text] [Related]
14. A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.
Moertel CG; Reitemeier RJ; Hahn RG
Cancer Res; 1967 Mar; 27(3):549-52. PubMed ID: 4225560
[No Abstract] [Full Text] [Related]
15. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
16. Experience with furanidyl-fluorouracil in advanced tumours of the breast.
Cichy A; Jurga L; Klvana M
Neoplasma; 1974; 21(6):723-32. PubMed ID: 4614094
[No Abstract] [Full Text] [Related]
17. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
Tormey DC; Gailani S; Leone L
Oncology; 1974; 29(3):244-8. PubMed ID: 4415043
[No Abstract] [Full Text] [Related]
18. Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
Gailani S; Holland JF; Falkson G; Leone L; Burningham R; Larsen V
Cancer; 1972 May; 29(5):1308-13. PubMed ID: 4623252
[No Abstract] [Full Text] [Related]
19. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
[No Abstract] [Full Text] [Related]
20. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
Aranda E; Cervantes A; Carrato A; Antón-Torres A; Massutí T; Fernández-Martos C; Díaz-Rubio E
J Infus Chemother; 1996; 6(3):118-22. PubMed ID: 9229321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
